• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EULAR 2023 recommendations for SLE treatment: synopsis for the management of lupus nephritis: the European Renal Association-Immunonephrology Working Group (ERA-IWG) perspective.

作者信息

Frangou Eleni, Bruchfeld Annette, Fernandez-Juarez Gema M, Floege Jürgen, Goumenos Dimitrios, Moran Sarah M, Steiger Stefanie, Stevens Kate I, Turkmen Kultigin, Kronbichler Andreas

机构信息

Department of Nephrology, Limassol General Hospital, Limassol, Cyprus; University of Nicosia Medical School, Nicosia, Cyprus.

Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

出版信息

Nephrol Dial Transplant. 2024 Apr 26;39(5):727-730. doi: 10.1093/ndt/gfad230.

DOI:10.1093/ndt/gfad230
PMID:37881002
Abstract
摘要

相似文献

1
EULAR 2023 recommendations for SLE treatment: synopsis for the management of lupus nephritis: the European Renal Association-Immunonephrology Working Group (ERA-IWG) perspective.欧洲抗风湿病联盟(EULAR)2023年系统性红斑狼疮治疗推荐:狼疮性肾炎管理概要:欧洲肾脏协会-免疫肾脏病学工作组(ERA-IWG)观点
Nephrol Dial Transplant. 2024 Apr 26;39(5):727-730. doi: 10.1093/ndt/gfad230.
2
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.2019 年更新版欧洲抗风湿病联盟与欧洲肾脏学会-欧洲透析和移植学会(EULAR/ERA-EDTA)狼疮肾炎管理建议。
Ann Rheum Dis. 2020 Jun;79(6):713-723. doi: 10.1136/annrheumdis-2020-216924. Epub 2020 Mar 27.
3
Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations.狼疮肾炎的治疗:系统文献回顾为 2019 年更新的 EULAR 和欧洲肾脏学会-欧洲透析和移植学会(EULAR/ERA-EDTA)建议提供信息。
RMD Open. 2020 Jul;6(2). doi: 10.1136/rmdopen-2020-001263.
4
Lupus nephritis: Transatlantic management recommendations compared.狼疮性肾炎:跨大西洋管理建议比较
Nat Rev Rheumatol. 2012 Dec;8(12):697-8. doi: 10.1038/nrrheum.2012.192. Epub 2012 Nov 13.
5
Overview of lupus nephritis management guidelines and perspective from Asia.狼疮性肾炎管理指南概述及亚洲视角
Int J Rheum Dis. 2013 Dec;16(6):625-36. doi: 10.1111/1756-185X.12212. Epub 2013 Oct 31.
6
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative.欧洲基于证据的儿童发病狼疮肾炎诊断和治疗推荐:SHARE 倡议。
Ann Rheum Dis. 2017 Dec;76(12):1965-1973. doi: 10.1136/annrheumdis-2017-211898. Epub 2017 Sep 6.
7
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.欧洲抗风湿病联盟和欧洲肾脏协会-欧洲透析和移植协会(EULAR/ERA-EDTA)成人和儿童狼疮肾炎管理建议。
Ann Rheum Dis. 2012 Nov;71(11):1771-82. doi: 10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31.
8
Lupus nephritis: guidelines for lupus nephritis--more recommendations than data?狼疮性肾炎:狼疮性肾炎指南——建议多于数据?
Nat Rev Nephrol. 2012 Nov;8(11):620-1. doi: 10.1038/nrneph.2012.215. Epub 2012 Sep 25.
9
Lupus nephritis: new progress in diagnosis and treatment.狼疮性肾炎:诊断与治疗的新进展。
J Autoimmun. 2022 Oct;132:102871. doi: 10.1016/j.jaut.2022.102871. Epub 2022 Aug 20.
10
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients.基于 2019 年 EULAR 建议的系统性红斑狼疮质量指标:在 220 例患者队列中的制定和初步验证。
Ann Rheum Dis. 2021 Sep;80(9):1175-1182. doi: 10.1136/annrheumdis-2021-220438. Epub 2021 Jun 23.

引用本文的文献

1
Heterogeneity of regional and national hospitalization burden of lupus nephritis and systemic lupus erythematous.狼疮性肾炎和系统性红斑狼疮区域及国家住院负担的异质性。
Clin Kidney J. 2025 Jul 1;18(7):sfaf162. doi: 10.1093/ckj/sfaf162. eCollection 2025 Jul.
2
Efficacy and safety of telitacicept in the treatment of systemic lupus erythematosus: A retrospective real-world study.泰它西普治疗系统性红斑狼疮的疗效与安全性:一项回顾性真实世界研究。
Lupus. 2025 May;34(6):597-607. doi: 10.1177/09612033251332052. Epub 2025 Apr 20.
3
Mechanisms Underlying Gender Influence on the Clinical Course and Immunopathogenesis of Systemic Lupus Erythematosus: An Explorative Review.
性别对系统性红斑狼疮临床病程及免疫发病机制影响的潜在机制:一项探索性综述
Cureus. 2024 Nov 13;16(11):e73646. doi: 10.7759/cureus.73646. eCollection 2024 Nov.
4
Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study.古塞库单抗治疗活动性狼疮性肾炎患者的疗效和安全性:一项2期随机安慰剂对照研究的结果
Rheumatology (Oxford). 2025 May 1;64(5):2731-2740. doi: 10.1093/rheumatology/keae647.